CSI Market
Sign In | Register

Kymera Therapeutics Inc (KYMR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KYMR Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Kymera Therapeutics Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent124.48
Combined Cash+Investments Total (filer-reported)1,505.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments124.00
Accounts receivable20.00
Prepaid Expense And Other Assets Current26.28
Total Current Assets737.27
Equipment/Property/Plant Net66.06
Long-term investments813.90
Other Assets, Noncurrent594.73
Contract With Customer Asset Net Current-
Operating Lease Right Of Use Asset41.74
Restricted Cash Noncurrent5.81
Total Assets1,645.44
Liabilities
Accounts Payable, Current AC8.92
Accrued Liabilities, Current AC48.48
Other Liabilities, Current13.93
Total Current Liabilities71.33
Total Long-term Debt0.00
Other liabilities, Noncurrent64.86
Contract With Customer Liability Current-
Operating Lease Liability Current12.03
Finance Lease Liability Current1.70
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent65.59
Finance Lease Liability Noncurrent1.15
Total Liabilities136.19
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock2,712.81
Retained Earnings / Accumulated Deficit-1,196.41
Accumulated Other Comprehensive Income-7.16
Other Equity-7.16
Common Stockholder's Equity1,509.26
Total Stockholder's Equity1,509.26
Liabilities & Stockholder's Equity1,645.44
4 historic quarters locked

Sign in to unlock the full Kymera Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Kymera Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-333849

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.